மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் ஆன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் ஆன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் ஆன் Today - Breaking & Trending Today

Pfizer Withdraws Emergency-Use Application for its COVID-19 Vaccine in India


Pfizer Withdraws Emergency-Use Application for its COVID-19 Vaccine in India
The Central Drugs Standard Control Organisation had earlier declined to approve Pfizer s vaccine without a small local trial on its safety and immunogenicity for Indians.
Syringes seen in front of BioNTech and Pfizer logos. Photo: Reuters/Dado Ruvic/File Photo.
Health05/Feb/2021
New Delhi: Pfizer Inc has withdrawn an application for emergency-use authorisation of its COVID-19 vaccine in India that it has developed with Germany’s BioNTech, the company told
Reuters on Friday.
The US company, which was the first drugmaker to apply for emergency use authorisation of its COVID-19 vaccine in India, had a meeting with the Central Drugs Standard Control Organisation on Wednesday and the decision was made after that, the company said. ....

New Delhi , Oxford University Astrazeneca , Indian Council Of Medical Research , Central Drugs Standard Control Organisation On , Central Drugs Standard Control Organisation , Bharat Biotech , Indian Council , New Drugs , Clinical Trial Rules , Bharat Biotech Vaccine , Biontech Pfizer , Corona Virus , Coronavirus Pandemic , Covid 19 Vaccine , Drugs Regulator , Emergency Use Authorisation , Latest Headlines , Latest News , Oxford Astrazeneca Vaccine , Pfizer Vaccine , Top Headlines , Top News , Top Stories , புதியது டெல்ஹி , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் ஆன் ,

Coronavirus | Experts raise questions over 'hasty' approval for COVID-19 vaccines


They advise against Covaxin, say there is no proof of efficacy.
Several experts have raised concern over the “hasty approval” granted to the COVID-19 vaccines despite the lack of adequate efficacy data.
The Central Drugs Standard Control Organisation on Sunday accorded approval for restricted emergency use of the Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute of India (SII), and the indigenously developed vaccine Covaxin of Bharat Biotech.
“I’m completely unaware of any data that suggests that Covaxin has any efficacy against any SARS-CoV-2 strain, let alone the U.K. strain,” Gagandeep Kang, Professor, Christian Medical College, Vellore, said in an interview to CNBC-TV18. ....

Central Drugs Standard Control Organisation On , Central Drugs Standard Control Organisation , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் ஆன் , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் ,

US daily deaths top 3,000: Virus Update


22
People drop off completed Covid-19 oral swab tests at a pop-up community testing site in the Panorama City neighbourhood of Los Angeles, California, on Wednesday. (AFP photo)
Deaths in the US from Covid-19 surpassed 3,000 a day for the first time, while Germany’s latest measures have so far failed to contain the spread in Europe’s largest economy. The UK’s vaccination campaign hit a stumbling block after two people with allergies experienced reactions to the Pfizer shot.
Pfizer said a cyberattack had exposed some documents filed with a European regulator relating to its vaccine review. India’s largest hospital chain said it’s ready to administer 1 million coronavirus vaccine doses a day. Passengers disembarked a cruise ship in Singapore after a Covid-19 scare on board. ....

Panorama City , United States , United Kingdom , White House , District Of Columbia , New Delhi , Rhode Island , South Africa , New Mexico , Soult Ukpyolsi , South Korea , South Dakota , Eastern Cape , South African , South Korean , Alex Azar , Angela Merkel , Yoshihide Suga , Donald Trump , Zweli Mkhize , Moncef Slaoui , Los Angeles , Suneeta Reddy , Johns Hopkins University , Apollo Hospitals Enterprise Ltd , Merck Co ,